Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
09May2025
  • Home
  • About
  • News
  • Subscribe
09May2025
Cost Curve NewsCost Curve News
Cost Curve News

New IQVIA Data Makes Clear Where Drug Prices Are, and Where They’re Going

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
12 months ago
Keep Reading
Cost Curve News

A New Campaign Unhelpfully Suggests that We ‘Fight Pharma.’ Sigh

One of the worst parts about living in 2024 is the widespread belief that seeking consensus is for suckers. The way to “win” is by ensuring that you can divide
12 months ago
Keep Reading
Cost Curve News

Past Panics About New-Med Introductions Have Been Overblown, With Lessons for Today’s Panics

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

Still Catching Up, With a Must-Read STAT Piece on Value, Thinking on Insulin, and More

Still living out of boxes here, but -- on the bright side -- it was steamers and oysters for lunch yesterday, so don’t shed any tears for me.  Still, there’s
1 year ago
Keep Reading
Cost Curve News

CMS Proposes New Rules on How It Will Implement the IRA

I’m to my eyeballs, quite literally, in moving boxes, but all of my possessions are now -- somewhere, theoretically -- inside my new home. The dog is adjusting. My back
1 year ago
Keep Reading
Cost Curve News

Witty Says UnitedHealth Doesn’t Own Any Drug Companies (Not Yet, Anyway)

Scheduling note: Curve off tomorrow. Might be off Monday, too. I’m headed east tomorrow morning, and I’m not stopping until I get to the Atlantic Ocean. There’s not much I
1 year ago
Keep Reading
Cost Curve News

The ‘Orange Book’ Brouhaha Keeps Ignoring the Elephant in the Room: the FDA

I mentioned yesterday that the first IRA lawsuit appeal -- the one backed by PhRMA -- will see the inside of a courtroom today. Audio details available here. The FTC
1 year ago
Keep Reading
Cost Curve News

California’s Efforts to Deliver Cheap Meds to Citizens Is Good and Noble (But Not a Drug-Price Revolution)

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

Questioning the Value of Obesity Meds Distracts from the Conversation We Should Be Having

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

Cigna’s Evernorth Unit Will Sell a Humira Biosimilar From Its Quallent Drug Company Through Its Accredo Pharmacy

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
212223

Latest Posts

Earnings Calls Are Chockablock With Policy Talk This Month: MFN, PBMs, 340B, and More

April 30, 2025

Novo and Telehealth Companies Team Up in the Next Turn of the Pharm-to-Table Story

April 29, 2025

Thoughts on an Arnold Ventures-Backed Poll on ‘Negotiations’ That Fails to Account for Access/Innovation Tradeoffs

April 28, 2025

Digging Even Deeper Into the Treasure Trove of the Cassidy Report on 340B

April 25, 2025

Senate Report on 340B Rams Home a Simple Message: The Program Is Broken

April 24, 2025

Popular

Earnings Calls Are Chockablock With Policy Talk This Month: MFN, PBMs, 340B, and More

Novo and Telehealth Companies Team Up in the Next Turn of the Pharm-to-Table Story

Thoughts on an Arnold Ventures-Backed Poll on ‘Negotiations’ That Fails to Account for Access/Innovation Tradeoffs

Digging Even Deeper Into the Treasure Trove of the Cassidy Report on 340B

Senate Report on 340B Rams Home a Simple Message: The Program Is Broken

More Evidence that the IRA’s Warped Incentives Are Reducing Research

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,009)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,233)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (993)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (974)
  • Looking Under the Hood at the Pricing Approach for the New Zepbound Obesity Med (922)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

Earnings Calls Are Chockablock With Policy Talk This Month: MFN, PBMs, 340B, and More

April 30, 2025

Novo and Telehealth Companies Team Up in the Next Turn of the Pharm-to-Table Story

April 29, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe